The PREDICTFTD project celebrated its Kick-off meeting on 23-24 January in Rotterdam, The Netherlands, marking the official start of an initiative focused on enhancing early diagnosis and care for patients with familial and sporadic Fronto-Temporal Dementia (FTD).
PREDICTFTD aims to validate a comprehensive set of biomarkers and develop a cutting-edge diagnostic tool that will enable early detection of FTD. This advancement is expected to significantly improve patient outcomes through tailored support, symptomatic treatments, and care strategies. Additionally, the project will harness AI-assisted, multi-modal, data-driven diagnostic algorithms to strengthen diagnostic precision.
The meeting served as an initial roundtable where project partners met face-to-face, fostering collaboration and knowledge exchange. It provided an excellent platform to showcase each partner’s expertise and set the foundation for effective project coordination.
Special mention to Erasmus University Medical Center, the project coordinator, for their leadership in steering the project towards its ambitious goals. Erasmus MC LinkedIn
Leitat’s Role:Leitat will play a key role in the project, leveraging its extensive expertise in biomarker analysis. The team will focus on detecting and quantifying inflammatory biomarkers in blood samples from both retrospective and current clinical trial patients, contributing critical insights to the project’s diagnostic advancements.
